Crossmark

Evaluating the clinical effects of GLP-1 receptor agonists for Alzheimer's and Parkinson's diseases using minimal clinically important difference: systematic review and meta-analysis

Crossref DOI link: https://doi.org/10.1007/s12272-026-01615-y

Published Online: 2026-05-07

Published Print: 2026-05

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Elghanam, Yomna https://orcid.org/0009-0007-9467-1313
Kim, Eunyoung https://orcid.org/0000-0003-3525-8805
Funding

Funding for this research was provided by:

Ministry of Science and ICT (NRF-2021R1F1A1062044)

Ministry of Education (NRF-2021R1A6A1A03044296)

Chung-Ang University
License Information

Text and Data Mining valid from 2026-05-01

Version of Record valid from 2026-05-07
More Information

Article History

Received: 13 March 2026

Accepted: 21 April 2026

First Online: 7 May 2026

Declarations

:

: Kim EY is an Editor of this journal, Archives of Pharmacal Research. However, her position did not influence the editorial handling or peer review process of this manuscript. The other author declares no conflict of interest.

: Not applicable.

Document is current

Any future updates will be listed below